Literature DB >> 18313251

Automated tryptic digestion procedure for HPLC/MS/MS peptide mapping of immunoglobulin gamma antibodies in pharmaceutics.

Dirk Chelius1, Gang Xiao, Andrew C Nichols, Alona Vizel, Bing He, Thomas M Dillon, Douglas S Rehder, Gary D Pipes, Edmund Kraft, Asha Oroska, Michael J Treuheit, Pavel V Bondarenko.   

Abstract

The rapid growth of antibody drugs and drug candidates in the biopharmaceutical industry has created a demand for automated proteolytic digestion to assist in pharmaceutical stability studies, identity assays and quality control of these therapeutic proteins. Here, we describe the development of a fully automated proteolytic digestion procedure for monoclonal antibodies in solution, which requires a high concentration of denaturants for unfolding. The antibody samples were placed in a 96-well plate or in 0.5-mL Eppendorf tubes. The proteins were then reduced and alkylated in a denaturing solution of 6M guanidine HCl. The denaturing solution was replaced with a digestion buffer using a custom-designed 96-well size-exclusion plate for desalting. The sample was digested for 5 h with two additions of trypsin. The completeness and reproducibility of digestion were verified by reversed-phase high-performance liquid chromatography tandem mass spectrometry (HPLC/MS) analysis of the digestion products. The performance of the automatic digestion was comparable to the currently used manual digestion procedure, but saved time, reduced manual labor, and increased the reproducibility of the tryptic digests. Our method should be useful not only for high-throughput analysis of antibodies, but for other therapeutic protein samples as well. Other applications like gel-free proteomics, where the analysis of a large number of samples is often needed and the completeness of the liquid digestion is critical for the identification of a large number of different proteins, should also benefit from this fully automated liquid proteolytic digestion procedure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313251     DOI: 10.1016/j.jpba.2008.01.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Detecting low level sequence variants in recombinant monoclonal antibodies.

Authors:  Yi Yang; Alex Strahan; Charlene Li; Amy Shen; Hongbin Liu; Jun Ouyang; Viswanatham Katta; Kathleen Francissen; Boyan Zhang
Journal:  MAbs       Date:  2010-05-06       Impact factor: 5.857

2.  Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer.

Authors:  Pavel V Bondarenko; Tonya P Second; Vlad Zabrouskov; Alexander A Makarov; Zhongqi Zhang
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-28       Impact factor: 3.109

3.  Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.

Authors:  Lei Zhu; Qingcheng Guo; Huaizu Guo; Tao Liu; Yingxin Zheng; Peiming Gu; Xi Chen; Hao Wang; Sheng Hou; Yajun Guo
Journal:  MAbs       Date:  2014       Impact factor: 5.857

4.  Rapid Highly-Efficient Digestion and Peptide Mapping of Adeno-Associated Viruses.

Authors:  Estee Naggar Toole; Craig Dufresne; Somak Ray; Alexander Schwann; Ken Cook; Alexander R Ivanov
Journal:  Anal Chem       Date:  2021-07-22       Impact factor: 6.986

5.  Exploring the analytical power of the QTOF MS platform to assess monoclonal antibodies quality attributes.

Authors:  Ricardo A Gomes; Conceição Almeida; Catarina Correia; Ana Guerreiro; Ana Luísa Simplício; Isabel A Abreu; Patrícia Gomes Alves
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.